标题
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 15, Pages 12222
出版商
MDPI AG
发表日期
2023-07-31
DOI
10.3390/ijms241512222
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bioinformatics toolbox for exploring target mutation-induced drug resistance
- (2023) Yuan-Qin Huang et al. BRIEFINGS IN BIOINFORMATICS
- Acquired resistance to EGFR-TKIs in NSCLC mediates epigenetic downregulation of MUC17 by facilitating NF-κB activity via UHRF1/DNMT1 complex
- (2023) Shuye Lin et al. International Journal of Biological Sciences
- Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
- (2023) Sanjit K. Roy et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance
- (2023) Fabian Fröhlich et al. Molecular Systems Biology
- Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance
- (2023) Eunkyung Han et al. MOLECULES
- Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression
- (2023) Zhenzhen Wei et al. Experimental and Therapeutic Medicine
- cRGD-targeted gold-based nanoparticles overcome EGFR-TKI resistance of NSCLC via low-temperature photothermal therapy combined with sonodynamic therapy
- (2023) Wenhao Lv et al. Biomaterials Science
- Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathway
- (2023) Jingjing Shi et al. Frontiers in Pharmacology
- Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
- (2023) Tina Draškovič et al. Cancers
- New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
- (2023) Pratibha Pandey et al. BIOMEDICINE & PHARMACOTHERAPY
- Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation
- (2023) Alexandra Mousset et al. CANCER CELL
- CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance
- (2023) Monique B. Nilsson et al. CANCER CELL
- Bionic lipoprotein loaded with chloroquine-mediated blocking immune escape improves antitumor immunotherapy
- (2023) Qing Dong et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
- (2023) Luis Vergara-Gómez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity
- (2023) Ashraf K. El-Damasy et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma
- (2023) Shuya Bai et al. Journal of Translational Medicine
- SNHG15 promotes chemoresistance and glycolysis in colorectal cancer
- (2023) Min Li et al. PATHOLOGY RESEARCH AND PRACTICE
- I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
- (2023) Congying Gao et al. Frontiers in Pharmacology
- Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
- (2023) Syue-Wei Peng et al. Cancers
- Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation
- (2023) Shohei Udagawa et al. Cancers
- Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review
- (2023) Aakash Desai et al. Translational Lung Cancer Research
- Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
- (2023) Jung Woo Eun et al. Cancer Communications
- Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer
- (2023) Bashir Lawal et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
- (2022) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer
- (2022) Anupama Modi et al. MOLECULAR BIOLOGY REPORTS
- Up-regulation of LncRNA UCA1 by TGF-β promotes doxorubicin resistance in breast cancer cells
- (2022) Like Wo et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
- (2022) Madhu Sharma et al. JOURNAL OF CONTROLLED RELEASE
- Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
- (2022) Zhenzhen Pan et al. Molecular Cancer
- Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
- (2022) Jianyou Gu et al. Molecular Cancer
- CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib
- (2022) Wei Qin et al. MOLECULAR CARCINOGENESIS
- Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling
- (2022) Suiying Liang et al. Bioengineered
- SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer
- (2022) Yonghui Liu et al. Cell Death Discovery
- Tamoxifen modulates mitochondrial dynamics through AMPK and MAPK during nutrition deprivation
- (2022) Gangipangi Vijayakumar et al. CELL BIOLOGY INTERNATIONAL
- The effects of REG4 expression on chemoresistance of ovarian cancer
- (2022) Li-Wei Xiang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models
- (2022) Stefania Cocco et al. Journal of Translational Medicine
- S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway
- (2022) Yan Sun et al. Cell Reports
- HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
- (2022) Milana A. Bergamino et al. EBioMedicine
- Cancer‐associated fibroblast‐derived exosomal microRNA‐20a suppresses the PTEN/PI3K‐AKT pathway to promote the progression and chemoresistance of non‐small cell lung cancer
- (2022) Lin Shi et al. Clinical and Translational Medicine
- PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer
- (2022) Qiyun Shi et al. BRITISH JOURNAL OF CANCER
- FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway
- (2022) Qian Wang et al. CANCER GENE THERAPY
- Elevated expression of LGR5 and WNT signalling factors in neuroblastoma cells with acquired drug resistance.
- (2022) John Clark-Corrigall et al. CANCER INVESTIGATION
- Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
- (2022) James T. Topham et al. JOURNAL OF CLINICAL ONCOLOGY
- DRESIS: the first comprehensive landscape of drug resistance information
- (2022) Xiuna Sun et al. NUCLEIC ACIDS RESEARCH
- EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
- (2022) Yubo Wang et al. Cell Death & Disease
- GPER induces mitochondrial fission through p44/42 MAPK - Drp1 pathway in breast cancer cells
- (2022) Pothuganti Rekha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells
- (2022) Wioleta Dudka et al. BMC CANCER
- HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
- (2022) Mei‐Qian Wang et al. CANCER SCIENCE
- PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
- (2022) Eyleen Corrales et al. Cell Communication and Signaling
- Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy
- (2022) Rui Sun et al. CELLULAR SIGNALLING
- CRISPR/Cas9 targeting liposomes knocked down multidrug resistance proteins in brain endothelial cells as a model to predict potential pharmacoresistance
- (2022) Tianzhi Yang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner
- (2022) Xi Lin et al. DRUG RESISTANCE UPDATES
- CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis
- (2022) Jing Wu et al. DRUG RESISTANCE UPDATES
- PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway
- (2022) Yuxiao Li et al. Genes & Genomics
- Cancer associated fibroblasts induce proliferation and therapeutic resistance to everolimus in neuroendocrine tumors through STAT3 activation
- (2022) Tania Amin et al. NEUROENDOCRINOLOGY
- Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia
- (2022) Dan Ma et al. ONCOGENE
- Chloroquine prevents hypoxic accumulation of HIF-1α by inhibiting ATR kinase: implication in chloroquine-mediated chemosensitization of colon carcinoma cells under hypoxia
- (2022) Changyu Kang et al. Pharmacological Reports
- Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib
- (2022) Yijie Zhang et al. Human Cell
- Autocrine EGF and TGF ‐α promote primary and acquired resistance to ALK / c‐Met kinase inhibitors in non‐small‐cell lung cancer
- (2022) Yueqin Wang et al. Pharmacology Research & Perspectives
- Expression analysis elucidates the roles of Nicastrin, Notch4, and Hes1 in prognosis and endocrine-therapy resistance in ER-positive breast cancer patients
- (2022) Fatemeh Mosaffa et al. Research in Pharmaceutical Sciences
- A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
- (2021) Fangzhen Lin et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Drug resistance and Cancer stem cells
- (2021) Yuan Li et al. Cell Communication and Signaling
- Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
- (2021) Keisuke Enomoto et al. Cancers
- Vascular normalisation as the stepping stone into tumour microenvironment transformation
- (2021) Anette L. Magnussen et al. BRITISH JOURNAL OF CANCER
- Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
- (2021) Shifaa M. Abdin et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Roles of CYP3A4, CYP3A5 and CYP2C8 drug-metabolizing enzymes in cellular cytostatic resistance
- (2021) Jakub Hofman et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer
- (2021) Huimin He et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Kinase drug discovery 20 years after imatinib: progress and future directions
- (2021) Philip Cohen et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids
- (2021) Martina Lepore Signorile et al. Cell Death & Disease
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
- (2021) Huan Xiao et al. Frontiers in Pharmacology
- miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway
- (2021) Caijin Zhou et al. JOURNAL OF CHEMOTHERAPY
- The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance
- (2021) Kangchen Chen et al. Cell Death & Disease
- LncRNA SNHG7 Regulates Mesenchymal Stem Cell Through the Notch1/Jagged1/Hes-1 Signaling Pathway and Influences Folfirinox Resistance in Pancreatic Cancer
- (2021) Dongfeng Cheng et al. Frontiers in Oncology
- ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
- (2021) Jing‐Quan Wang et al. Journal of Evidence-Based Medicine
- DEHP mediates drug resistance by directly targeting AhR in human breast cancer
- (2021) Tsung-Hua Hsieh et al. BIOMEDICINE & PHARMACOTHERAPY
- Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
- (2021) Lu Jiang et al. BMC CANCER
- Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma
- (2021) Qitai Zhao et al. CANCER LETTERS
- Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
- (2021) Alvaro Quintanal-Villalonga et al. Journal of Hematology & Oncology
- The role of tumor acidification in aggressiveness, cell dissemination and treatment resistance of oral squamous cell carcinoma
- (2021) Bianca de Bem Prunes et al. LIFE SCIENCES
- A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects
- (2021) Ho Jin Lee et al. Theranostics
- The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer
- (2021) Zhijian Jin et al. Redox Biology
- The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2021) Yali Cheng et al. Frontiers in Oncology
- Framing cancer progression: influence of the organ‐ and tumour‐specific matrisome
- (2020) Maria Rafaeva et al. FEBS Journal
- The landscape of BCR‐ABL mutations in patients with Philadelphia chromosome‐positive leukaemias in the era of second‐generation tyrosine kinase inhibitors
- (2020) Sheng‐Hsuan Chien et al. HEMATOLOGICAL ONCOLOGY
- Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
- (2020) Maryam Majidinia et al. IUBMB LIFE
- Regenerative lineages and immune-mediated pruning in lung cancer metastasis
- (2020) Ashley M. Laughney et al. NATURE MEDICINE
- Divergent mutational processes distinguish hypoxic and normoxic tumours
- (2020) Vinayak Bhandari et al. Nature Communications
- Response and Resistance to BCR-ABL1-Targeted Therapies
- (2020) Theodore P. Braun et al. CANCER CELL
- Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
- (2020) Rongdang Fu et al. MEDICAL ONCOLOGY
- FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
- (2020) Qiong Wu et al. Molecular Oncology
- Therapeutic Nanoparticles and Their Targeted Delivery Applications
- (2020) Abuzer Alp Yetisgin et al. MOLECULES
- Pancreatic cancer stroma: an update on therapeutic targeting strategies
- (2020) Abdel N. Hosein et al. Nature Reviews Gastroenterology & Hepatology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
- (2020) Prathibha Kirave et al. Oncotarget
- Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss
- (2020) Nicci Owusu-Brackett et al. Oncotarget
- Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
- (2020) Yena Cho et al. Frontiers in Oncology
- Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival
- (2020) Syed H. Zaidi et al. Nature Communications
- Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
- (2020) Douglas K. Marks et al. Frontiers in Oncology
- Recent advances in drug delivery systems for targeting cancer stem cells
- (2020) Hongxia Duan et al. Acta Pharmaceutica Sinica B
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- MEK inhibitor resistance mechanisms and recent developments in combination trials
- (2020) E. Kun et al. CANCER TREATMENT REVIEWS
- Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
- (2020) Elke Kaemmerer et al. DRUG DISCOVERY TODAY
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Importance of m N6-methyladenosine (m6A) RNA modification in cancer
- (2019) Gulten Tuncel et al. MEDICAL ONCOLOGY
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long noncoding RNA NEAT1 suppresses sorafenib sensitivity of hepatocellular carcinoma cells via regulating miR‐335–c‐Met
- (2019) Shuwei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
- (2019) Junli Deng et al. BMC CANCER
- Exosomes and their role in tumorigenesis and anticancer drug resistance
- (2019) Neta Milman et al. DRUG RESISTANCE UPDATES
- Insights into new mechanisms and models of cancer stem cell multidrug resistance
- (2019) Y. Garcia-Mayea et al. SEMINARS IN CANCER BIOLOGY
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
- (2019) Aparna R. Parikh et al. NATURE MEDICINE
- Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma
- (2019) Megan A. Hatlen et al. Cancer Discovery
- Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
- (2019) Lichun Ma et al. CANCER CELL
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
- (2019) Karen G. de la Cruz-López et al. Frontiers in Oncology
- KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
- (2019) Tian Lan et al. Molecular Cancer
- MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer
- (2019) Wei Guo et al. MEDICAL SCIENCE MONITOR
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
- (2018) Alexandru D. Buhimschi et al. BIOCHEMISTRY
- PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy
- (2018) Limei Yin et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
- (2018) Rona Yaeger et al. CANCER CELL
- Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
- (2018) Daoxiang Zhang et al. CANCER RESEARCH
- Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis
- (2018) Galileo A. Gonzalez-Conchas et al. CANCER TREATMENT REVIEWS
- Toward Minimal Residual Disease-Directed Therapy in Melanoma
- (2018) Florian Rambow et al. CELL
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- The Emerging Therapeutic Landscape of Advanced Melanoma
- (2018) Vanessa Henriques et al. CURRENT PHARMACEUTICAL DESIGN
- Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells
- (2018) Majid Momeny et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
- (2018) Yuhong Lu et al. MOLECULAR CANCER RESEARCH
- Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
- (2018) Xiao-Yuan Mao et al. PHARMACOLOGY & THERAPEUTICS
- Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer
- (2018) Yen-An Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism
- (2018) Yang Yang et al. TOXICOLOGY LETTERS
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance
- (2018) Yun Che et al. Cell Death & Disease
- Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
- (2018) Christophe Deben et al. Cancers
- VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation
- (2018) Yanan Yue et al. Cell Discovery
- Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models
- (2018) Caitlin D Lowery et al. CLINICAL CANCER RESEARCH
- Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells
- (2017) Zhiqiang Wang et al. EXPERIMENTAL CELL RESEARCH
- SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway
- (2017) S.-L. Xie et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
- (2017) Dimakatso Alice Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ras–MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
- (2017) Ho-June Lee et al. MOLECULAR CANCER THERAPEUTICS
- Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
- (2017) Yoshiteru Ohata et al. MOLECULAR CANCER THERAPEUTICS
- Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
- (2017) Lanfang Zhang et al. MOLECULAR CARCINOGENESIS
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
- (2017) Shaomeng Wang et al. Cold Spring Harbor Perspectives in Medicine
- Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
- (2017) Jennifer Peyling Wang et al. Journal of Cancer
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis
- (2016) Xiao-Yuan Mao et al. CANCER LETTERS
- To wake up cancer stem cells, or to let them sleep, that is the question
- (2016) Shoichiro Takeishi et al. CANCER SCIENCE
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
- (2016) Svetlana Skolekova et al. Cell Communication and Signaling
- Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation
- (2016) Silvia Peppicelli et al. CELL CYCLE
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway
- (2016) Yihao Zhang et al. LABORATORY INVESTIGATION
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
- (2016) Qing Chen et al. NATURE
- Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
- (2016) Marco Demaria et al. Cancer Discovery
- Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
- (2016) Jocelyn P. Wong et al. Cell Reports
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition
- (2016) Dongsheng Huang et al. Scientific Reports
- Resveratrol nanoformulation for cancer prevention and therapy
- (2015) Imtiaz A. Siddiqui et al. Annals of the New York Academy of Sciences
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
- (2015) Humsa S. Venkatesh et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
- (2015) Victoria Tovar et al. GUT
- 5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells
- (2015) Zhi-Yuan Xu et al. International Journal of Biological Sciences
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Neural Regulation of Hematopoiesis, Inflammation, and Cancer
- (2015) Maher Hanoun et al. NEURON
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- pH Gradient Reversal: An Emerging Hallmark of Cancers
- (2015) Mohit Sharma et al. Recent Patents on Anti-Cancer Drug Discovery
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- The mechanical microenvironment in cancer: How physics affects tumours
- (2015) Anika Nagelkerke et al. SEMINARS IN CANCER BIOLOGY
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
- (2015) Min-Che Tung et al. Oncotarget
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- The molecular mechanisms underlying the therapeutic resistance of cancer stem cells
- (2014) Jun-Kyum Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Transcriptional Dynamics in Colorectal Carcinogenesis: New Insights into the Role of c-Myc and miR17 in Benign to Cancer Transformation
- (2014) E. Ben-David et al. CANCER RESEARCH
- Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition
- (2014) T. Troiani et al. CLINICAL CANCER RESEARCH
- Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells
- (2014) Myoung-Eun Han et al. JOURNAL OF GASTROENTEROLOGY
- A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
- (2014) Haihui Lu et al. NATURE CELL BIOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The chemistry, physiology and pathology of pH in cancer
- (2014) P. Swietach et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin
- (2014) Cristina Federici et al. PLoS One
- Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies
- (2014) Chong Sun et al. TRENDS IN BIOCHEMICAL SCIENCES
- Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the fr
- (2013) Simona Soverini et al. CANCER
- PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells
- (2013) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-like Cell Maintenance and Tumorigenicity in Prostate Cancer
- (2013) G. Civenni et al. CANCER RESEARCH
- Adding a new facet to STAT5 in CML: Multitasking for leukemic cells
- (2013) Wolfgang Warsch et al. CELL CYCLE
- ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
- (2013) Yan Zhang et al. CELL RESEARCH
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation
- (2013) Mirjam Stahl et al. PLoS One
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- Pericellular pH homeostasis is a primary function of the Warburg effect: Inversion of metabolic systems to control lactate steady state in tumor cells
- (2012) Elizabeth A. Mazzio et al. CANCER SCIENCE
- P53 Mdm2 Inhibitors
- (2012) Kareem Khoury et al. CURRENT PHARMACEUTICAL DESIGN
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- Cellular senescence and cancer chemotherapy resistance
- (2012) Ryan R. Gordon et al. DRUG RESISTANCE UPDATES
- Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic
- (2012) Youhong Liu et al. MOLECULAR CARCINOGENESIS
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma
- (2012) Nadia Lago Costa et al. ORAL ONCOLOGY
- Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer
- (2012) Ming Ming Zhu et al. PLoS One
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- (2012) T. A. Yap et al. Science Translational Medicine
- Phthalates Stimulate the Epithelial to Mesenchymal TransitionThrough an HDAC6-Dependent Mechanism in Human BreastEpithelial Stem Cells
- (2012) Tsung-Hua Hsieh et al. TOXICOLOGICAL SCIENCES
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
- (2012) Xue Xue et al. Chinese Journal of Cancer
- Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells
- (2011) Jayashree P. Joshi et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: Implications for drug resistance and in vitro drug screening models
- (2011) Michal Sabisz et al. CELL CYCLE
- PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
- (2011) Francesco Dituri et al. Clinical & Developmental Immunology
- Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development
- (2011) K Moitra et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Donggen Liu et al. MEDICAL ONCOLOGY
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors
- (2011) P. L. Bollyky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- (2010) Mothaffar F. Rimawi et al. CANCER
- Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
- (2010) X. H. Yang et al. CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Tumors as Organs: Complex Tissues that Interface with the Entire Organism
- (2010) Mikala Egeblad et al. DEVELOPMENTAL CELL
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
- (2010) L Sauer et al. ONCOGENE
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Sensors and regulators of intracellular pH
- (2009) Joseph R. Casey et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A common gain of function of p53 cancer mutants in inducing genetic instability
- (2009) D P Liu et al. ONCOGENE
- SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
- (2009) A. E. Sayan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1)in vitroandin vivoby increasing the activity of the p-glycoproteinviaactivation of p38
- (2008) Christoph Sauvant et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity
- (2008) Audrey Sermeus et al. Molecular Cancer
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now